TAVANTA THERAPEUTICS

Tavanta Therapeutics operates as a clinical-stage generic pharmaceutical firm that developing a diverse pipeline of innovative drugs that bring clinically meaningful benefits to patients with serious or debilitating diseases. It has built a product portfolio that includes early research and late clinical development of novel specialty drugs for patients with unmet medical needs. It aims to improve the lives of patients with serious medical disorders in which existing treatments are inadequate. Their pipeline of drugs includes treatment for metastatic castration-resistant prostate cancer and high-risk metastatic castration-sensitive prostate cancer, tuberous sclerosis complex, cystic fibrosis, multiple sclerosis, and more.